About Metlife Pharmaceuticals Private Limited
Data last updated:
Metlife Pharmaceuticals Private Limited is a private limited company based in Jogeshwari West, Maharashtra, India. It was incorporated on 25 April 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2024PTC424084.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nagajyothi Chandrapati and Rajasekhar Reddy Yeruva.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jogeshwari West, Maharashtra.
As per MCA filings, the company has open charges of ₹1 Cr on record.
For more details, the company can be reached via its website metlifepharma.com.
Company details
Contact details
Metlife Pharmaceuticals Private Limited's registered office is in Jogeshwari West, Maharashtra.
- Registered AddressUnitno.611 6 Flr Reliable, Business Center Anandnagr, Jogeshwari West, Maharashtra, India – 400102
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Metlife Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Metlife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Metlife Pharmaceuticals Private Limited
Metlife Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagajyothi Chandrapati | Director | 25 Apr 2024 | 2 Years 6 Months | Current |
| Atmakoor Anil Kumar Also directs: Drithi Cold Storage LLP | Additional Director | 03 Dec 2025 | 0 Years 11 Months | Current |
| Rajasekhar Reddy Yeruva | Director | 25 Apr 2024 | 2 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Nov 2025 | 101230385 | Hdfc Bank Limited | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Metlife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metlife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Metlife Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Metlife Pharmaceuticals Private Limited has 3 board changes on record since 2024: 3 appointments. The latest: Atmakoor Anil Kumar was appointed as Additional Director on 03 Dec 2025.
Frequently asked questions
Metlife Pharmaceuticals is an active private limited company based in Jogeshwari West, Maharashtra, India. It was incorporated on 25 April 2024 (2+ years old) and is registered under CIN U47721MH2024PTC424084.
Metlife Pharmaceuticals has 3 current directors:
- Nagajyothi Chandrapati - Director
- Atmakoor Anil Kumar - Additional Director
- Rajasekhar Reddy Yeruva - Director
The latest financial statements of Metlife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Metlife Pharmaceuticals is U47721MH2024PTC424084. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metlife Pharmaceuticals was incorporated on 25 April 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
Atmakoor Anil Kumar was appointed as Additional Director on 03 Dec 2025. Nagajyothi Chandrapati was appointed as Director on 25 Apr 2024. Rajasekhar Reddy Yeruva was appointed as Director on 25 Apr 2024.
Metlife Pharmaceuticals can be reached through the website metlifepharma.com. Its registered office is in Jogeshwari West, Maharashtra, India.
The registered office of Metlife Pharmaceuticals is at Unitno.611 6 Flr Reliable, Business Center Anandnagr, Jogeshwari West, Maharashtra, India – 400102.
Metlife Pharmaceuticals has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Metlife Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
